Fisher & Paykel Healthcare — Fact Sheet (2026)

4 slides from Fisher & Paykel Healthcare's fact sheet, 2026

Slide 1: Fact Sheet 2026
Fact Sheet 2026 Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, OPERATING REVENUE PROFIT AFTER TAX1 surgery and the treatment of obstructive sleep apnea. NZ$ MILLIONS NZ$ MILLIONS 2,308.4 524.2 Our pur
Slide 2: Product Groups
PRODUCT GROUPS Hospital We offer medical devices for use in the hospital where patients are receiving invasive and noninvasive ventilation, nasal high flow therapy or undergoing surgery. Humidity is crucial to respiratory health and wellbeing. Our products incorporate patented <1% and proprietary te
Slide 3: Markets, Governance - Board, Capital Management, R&D
MARKETS GOVERNANCE - BOARD We employ multiple distribution channels to reach our customers in more than 120 countries. Neville Mitchell - Chair, Non-Executive Mark Cross - Non-Executive Independent Director Independent Director Direct: We have direct sales teams in 55 countries, who sell directly to
Slide 4: History, Analysts, Investor Relations
HISTORY ANALYSTS Fisher & Paykel Healthcare was established in 1969 in New Zealand. Three pioneering problem- A number of broking analysts currently follow our company and provide written research reports solvers – Auckland Hospital intensive care specialist Dr Matt Spence, government electrical on